Of these, mutations in CREBBP, KMT2D, TNFRSF14 and RRAGC were enriched in follicular lymphoma, and those of BTG2, HLA-A, PIM1, IGLL5, SOCS1, CD83 and SGK1 were enriched in DLBCL. Here, CREBBP is linked to diffuse large B-cell lymphoma.